David Kaminski Email & Phone Number

Parsippany, New Jersey, US

Developed and implemented consumer marketing materials for NUCALA, an anti-IL5 biologic, at GSK

Handled the development, approval and production of marketing materials for cardiovascular and mature brands at a large multinational pharmaceutical company

Conshohocken, Pennsylvania, US

Fostered and facilitated healthcare professional marketing for resmetirom, a thyroid hormone receptor beta-selective agonist in development for nonalcoholic steatohepatitis (NASH). Led and managed launch preparation activities to include disease-state education, advertising campaign, conference activities and peer-to-peer education programs.

Cambridge, MA, US

• Facilitated healthcare professional marketing for tebipenem, an oral carbapenem antibiotic. Led and managed launch preparation activities to include brand development, packaging creative, disease-state education.
• Drove development of branding for tebipenem including name, logo, brand persona and packaging
• Launched disease-state education campaign to raise HCP awareness of the company and the need for new oral antibiotics
• Developed branded messages and the creative advertising campaign for launch
• Supervised one direct report responsible for the development and management of promotional speaker programs

Boston, MA, US

• Led healthcare professional marketing and launch preparation activities for NUZYRA, a tetracycline-derivative antibiotic, in both hospital and community settings.
• Led development of the hospital advertising campaign, messaging and infectious disease HCP marketing materials
• Headed a cross-functional team to initiate pilot program for promotion of NUZYRA to primary care physicians
• Generated deep customer insights on launch materials, speaker programs and infusion center strategies through advisory boards conducted with thought leaders and key customers
• Increased physician awareness of NUZYRA through multi-channel marketing programs including improvement of salesforce materials and non-personal promotion

• Utilized marketing and pharmaceutical experience to make brands and companies more successful.
• Handled the development, approval and production of managed care pull-through materials for an opioid-induced constipation brand at a large multinational pharmaceutical company
• Created and managed corporate website and social media for a start-up pharmaceutical company

US

• Managed overall strategy, execution and measurement of men’s health portfolio consumer marketing programs. Key brands included EDEX, STENDRA, TESTIM, TESTOPEL and XIAFLEX. Implemented digital marketing assets including.
• Led development of award winning XIAFLEX consumer campaign for Dupuytren’s Contracture
• Created customer relationship marketing program with multiple email touchpoints designed to educate consumers, drive consumers to their doctor and foster conversion
• Guided media strategy, purchase and measurement across portfolio

Cambridge, Cambridgeshire, GB

• Handled strategy, execution and measurement of CRESTOR consumer marketing programs with emphasis in relationship marketing, co-pay savings card programs and digital.
• Oversaw opt-in database direct marketing activities including conversion, loyalty and re-contact programs. Program increased adherence by 13% with an ROI of 1.7 to 1
• Developed and implemented co-pay savings card, free trial certificate and pharmacy tear-pad programs designed to address consumer cost concerns. Programs resulted in over 848,000 annual redemptions with $35 Million.
• Implemented consumer digital marketing tactics including web-site design, web portal partnerships, search engine optimization and digital media
• Developed and implemented pharmacy-based acquisition and loyalty/refill-reminder programs with ROIs up to 2.7 to 1

Cambridge, Cambridgeshire, GB

Developed and implemented innovative adherence practices with consumers, healthcare professionals, managed care organizations and pharmacy customers.

Cambridge, Cambridgeshire, GB

Led a cross-functional team to provide global commercial input for the decision to enter phase 3 clinical trials for BRILINTA, an oral anti-platelet in development for arterial thrombosis.

Cambridge, Cambridgeshire, GB

Delivered strategic insight for commercial assessments of products in early phases of development in dyslipidemia, atrial fibrillation and type 2 diabetes.

Leverkusen, North Rhine-Westphalia, DE

Conducted market research to support US commercial input for pre-launch products and in-licensing candidates in oncology, cardiovascular, asthma and multiple sclerosis.

Master Of Business Administration - Mba, Pharmaceutical Studies

Bachelor Of Science - Bs, Chemistry